Cargando…
Research imperative
There is a note of caution expressed when clinical care providers enroll their own patients into investigational trials, a concern expressed in the called dual-role consent. There is concern that this circumstance may create a conflict of interest for the physician-investigator, lead to loss of pati...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461583/ https://www.ncbi.nlm.nih.gov/pubmed/31011655 http://dx.doi.org/10.1016/j.conctc.2019.100350 |
_version_ | 1783410500802969600 |
---|---|
author | Trachtman, Howard |
author_facet | Trachtman, Howard |
author_sort | Trachtman, Howard |
collection | PubMed |
description | There is a note of caution expressed when clinical care providers enroll their own patients into investigational trials, a concern expressed in the called dual-role consent. There is concern that this circumstance may create a conflict of interest for the physician-investigator, lead to loss of patient voluntarism, and promote the therapeutic misconceptions. In this opinion paper, I review the circumstances surrounding participation in clinical research and the conduct of standard patient care. I propose that when a patient is eligible for an institutional review board-approved clinical trial, instead of representing a potential ethical lapse, soliciting enrollment by the clinician-researcher may represent optimal care for the patient. |
format | Online Article Text |
id | pubmed-6461583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64615832019-04-22 Research imperative Trachtman, Howard Contemp Clin Trials Commun Article There is a note of caution expressed when clinical care providers enroll their own patients into investigational trials, a concern expressed in the called dual-role consent. There is concern that this circumstance may create a conflict of interest for the physician-investigator, lead to loss of patient voluntarism, and promote the therapeutic misconceptions. In this opinion paper, I review the circumstances surrounding participation in clinical research and the conduct of standard patient care. I propose that when a patient is eligible for an institutional review board-approved clinical trial, instead of representing a potential ethical lapse, soliciting enrollment by the clinician-researcher may represent optimal care for the patient. Elsevier 2019-03-24 /pmc/articles/PMC6461583/ /pubmed/31011655 http://dx.doi.org/10.1016/j.conctc.2019.100350 Text en © 2019 The Author http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Trachtman, Howard Research imperative |
title | Research imperative |
title_full | Research imperative |
title_fullStr | Research imperative |
title_full_unstemmed | Research imperative |
title_short | Research imperative |
title_sort | research imperative |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461583/ https://www.ncbi.nlm.nih.gov/pubmed/31011655 http://dx.doi.org/10.1016/j.conctc.2019.100350 |
work_keys_str_mv | AT trachtmanhoward researchimperative |